» Articles » PMID: 12091393

A Rhodopsin Mutant Linked to Autosomal Dominant Retinitis Pigmentosa is Prone to Aggregate and Interacts with the Ubiquitin Proteasome System

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Jul 2
PMID 12091393
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

The inherited retinal degenerations are typified by retinitis pigmentosa (RP), a heterogeneous group of inherited disorders that causes the destruction of photoreceptor cells, the retinal pigmented epithelium, and choroid. This group of blinding conditions affects over 1.5 million persons worldwide. Approximately 30-40% of human autosomal dominant (AD) RP is caused by dominantly inherited missense mutations in the rhodopsin gene. Here we show that P23H, the most frequent RP mutation in American patients, renders rhodopsin extremely prone to form high molecular weight oligomeric species in the cytoplasm of transfected cells. Aggregated P23H accumulates in aggresomes, which are pericentriolar inclusion bodies that require an intact microtubule cytoskeleton to form. Using fluorescence resonance energy transfer (FRET), we observe that P23H aggregates in the cytoplasm even at extremely low expression levels. Our data show that the P23H mutation destabilizes the protein and targets it for degradation by the ubiquitin proteasome system. P23H is stabilized by proteasome inhibitors and by co-expression of a dominant negative form of ubiquitin. We show that expression of P23H, but not wild-type rhodopsin, results in a generalized impairment of the ubiquitin proteasome system, suggesting a mechanism for photoreceptor degeneration that links RP to a broad class of neurodegenerative diseases.

Citing Articles

Endoplasmic reticulum stress and rhodopsin accumulation in an organoid model of Retinitis Pigmentosa carrying a RHO pathogenic variant.

Navines-Ferrer A, Pomares E Stem Cell Res Ther. 2025; 16(1):71.

PMID: 39948682 PMC: 11827366. DOI: 10.1186/s13287-025-04199-4.


Translational Research and Therapies for Neuroprotection and Regeneration of the Optic Nerve and Retina: A Narrative Review.

Oshitari T Int J Mol Sci. 2024; 25(19).

PMID: 39408817 PMC: 11476551. DOI: 10.3390/ijms251910485.


Therapeutic potential of archaeal unfoldase PANet and the gateless T20S proteasome in P23H rhodopsin retinitis pigmentosa mice.

Brooks C, Kolson D, Sechrest E, Chuah J, Schupp J, Billington N PLoS One. 2024; 19(10):e0308058.

PMID: 39361629 PMC: 11449290. DOI: 10.1371/journal.pone.0308058.


The New Era of Therapeutic Strategies for the Management of Retinitis Pigmentosa: A Narrative Review of the Pathomolecular Mechanism for Gene Therapies.

Nair P, Keskar M, Borghare P, Dzoagbe H, Kumar T Cureus. 2024; 16(8):e66814.

PMID: 39280562 PMC: 11393205. DOI: 10.7759/cureus.66814.


Preservation of retinal structure and function in two mouse models of inherited retinal degeneration by ONL1204, an inhibitor of the Fas receptor.

Yang M, Yao J, Jia L, Kocab A, Zacks D Cell Death Dis. 2024; 15(8):576.

PMID: 39117629 PMC: 11310419. DOI: 10.1038/s41419-024-06970-6.